Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
A Phase III, Randomized, Open-label Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy as First-Line Therapy in Patients With EGFR-Mutant Locally Advanced or Metastatic Non-small Cell Lung Cancer
3 other identifiers
interventional
850
15 countries
200
Brief Summary
The purpose of this study is to evaluate izalontamab brengitecan (iza-bren) combined with osimertinib in participants with previously untreated, locally advanced or metastatic EGFR-mutant NSCLC, compared to osimertinib alone or osimertinib combined with platinum-based chemotherapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 nonsmall-cell-lung-cancer
Started Sep 2026
Typical duration for phase_3 nonsmall-cell-lung-cancer
200 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2026
CompletedFirst Posted
Study publicly available on registry
July 2, 2026
CompletedStudy Start
First participant enrolled
September 30, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2031
Study Completion
Last participant's last visit for all outcomes
December 30, 2031
July 15, 2026
July 1, 2026
5.3 years
June 26, 2026
July 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Progression-Free Survival (PFS) using blinded independent central review (BICR) assessment as defined by Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1)
Up to approximately 3 years
Secondary Outcomes (9)
Overall Survival (OS)
Up to approximately 5 years
PFS assessed by the investigator as per RECIST v1.1
Up to approximately 3 years
Second Progression-Free Survival (PFS2) as assessed by the Investigator
Up to approximately 5 years
Objective Response Rate (ORR) assessed by the BICR as per RECIST v1.1
Up to approximately 3 years
Objective Response Rate (ORR) assessed by the investigator as per RECIST v1.1
Up to approximately 3 years
- +4 more secondary outcomes
Study Arms (2)
Arm A
EXPERIMENTALArm B
ACTIVE COMPARATORInterventions
Specified dose on specified days
Eligibility Criteria
You may qualify if:
- Participants must have histologically or cytologically confirmed non-squamous NSCLC, newly diagnosed locally advanced (Stage IIIB/IIIC), metastatic (Stage IVA/IVB), or recurrent disease not amenable to curative surgery or definitive radiotherapy and requiring systemic treatment
- Participants must have documented EGFR-TKI-sensitizing mutation (exon 19 deletion or exon 21 L858R substitution)
- Participants must have measurable extracranial disease per RECIST v1.1 as assessed by the investigator
- Participants must have ECOG Performance Status 0-1
You may not qualify if:
- Participants must not have unstable, symptomatic, or uncontrolled CNS metastases, including brain, leptomeningeal disease, and/or spinal cord compression
- Participants must not have history of ILD/pneumonitis requiring treatment with steroids (≥ Grade 2), or current or suspected ILD/pneumonitis
- Participants must not have clinically significant cardiac disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (200)
Local Institution - 0212
Beverly Hills, California, 90211, United States
Local Institution - 0504
Fullerton, California, 92835, United States
Local Institution - 0357
La Jolla, California, 92093, United States
Local Institution - 0520
Pueblo, Colorado, 81003, United States
Local Institution - 0527
Fort Myers, Florida, 33901, United States
Local Institution - 0366
Orlando, Florida, 32806, United States
Local Institution - 0519
Palm Bay, Florida, 32901, United States
Local Institution - 0210
Honolulu, Hawaii, 96813, United States
Local Institution - 0207
Ottawa, Illinois, 61350, United States
Local Institution - 0503
Baltimore, Maryland, 21202, United States
Local Institution - 0523
Silver Spring, Maryland, 20904, United States
Local Institution - 0521
Edina, Minnesota, 55435, United States
Local Institution - 0364
Saint Paul, Minnesota, 55102, United States
Local Institution - 0403
St Louis, Missouri, 63110, United States
Local Institution - 0402
Omaha, Nebraska, 68198, United States
Local Institution - 0290
Lebanon, New Hampshire, 03756, United States
Local Institution - 0183
New Brunswick, New Jersey, 08901, United States
Local Institution - 0153
New York, New York, 10021, United States
Local Institution - 0157
The Bronx, New York, 10461, United States
Local Institution - 0385
Charlotte, North Carolina, 28204, United States
Local Institution - 0438
Sandusky, Ohio, 44870, United States
Local Institution - 0404
Portland, Oregon, 97213, United States
Local Institution - 0487
Easton, Pennsylvania, 18045, United States
Local Institution - 0200
Sioux Falls, South Dakota, 57105, United States
Local Institution - 0199
Memphis, Tennessee, 38120, United States
Local Institution - 0522
Beaumont, Texas, 77702, United States
Local Institution - 0525
Dallas, Texas, 75246, United States
Local Institution - 0529
San Antonio, Texas, 78217, United States
Local Institution - 0411
Salt Lake City, Utah, 84112, United States
Local Institution - 0165
Fairfax, Virginia, 22031, United States
Local Institution - 0530
Fairfax, Virginia, 22031, United States
Local Institution - 0528
Winchester, Virginia, 22601, United States
Local Institution - 0283
Seattle, Washington, 98104, United States
Local Institution - 0502
Morgantown, West Virginia, 26505, United States
Local Institution - 0077
Mar del Plata, Buenos Aires, B7602CBM, Argentina
Local Institution - 0514
Río Cuarto, Córdoba Province, 5800, Argentina
Local Institution - 0086
Buenos Aires, C1122AAL, Argentina
Local Institution - 0432
Buenos Aires, C1199ABB, Argentina
Local Institution - 0085
Buenos Aires, C1280AEB, Argentina
Local Institution - 0078
Buenos Aires, C1426AGE, Argentina
Local Institution - 0151
Buenos Aires, C1426ANZ, Argentina
Local Institution - 0424
Camperdown, New South Wales, 2050, Australia
Local Institution - 0439
Westmead, New South Wales, 2145, Australia
Local Institution - 0511
Greenslopes, Queensland, 4120, Australia
Local Institution - 0492
Adelaide, South Australia, 5000, Australia
Local Institution - 0447
Clayton, Victoria, 3168, Australia
Local Institution - 0437
Murdoch, Western Australia, 6150, Australia
Local Institution - 0253
Vitória, Espírito Santo, 29043-260, Brazil
Local Institution - 0291
Salvador, Estado de Bahia, 40170-110, Brazil
Local Institution - 0247
Ijuí, Rio Grande do Sul, 98700-000, Brazil
Local Institution - 0252
Florianópolis, Santa Catarina, 88020, Brazil
Local Institution - 0244
Barretos, São Paulo, 14784-400, Brazil
Local Institution - 0249
Campinas, São Paulo, 13060-803, Brazil
Local Institution - 0261
Sorocaba, São Paulo, 18030-005, Brazil
Local Institution - 0255
Rio de Janeiro, 20230-130, Brazil
Local Institution - 0259
São Paulo, 01246-000, Brazil
Local Institution - 0059
Edmonton, Alberta, T6G1Z2, Canada
Local Institution - 0494
Abbotsford British Columbia, British Columbia, V2S0C2, Canada
Local Institution - 0056
Vancouver, British Columbia, V5Z4E6, Canada
Local Institution - 0533
Oakville, Ontario, L6M 0L8, Canada
Local Institution - 0043
Oshawa, Ontario, L1G2B9, Canada
Local Institution - 0012
Toronto, Ontario, M4N3M5, Canada
Local Institution - 0045
Toronto, Ontario, M5G2M9, Canada
Local Institution - 0407
Laval, Quebec, H7M3L9, Canada
Local Institution - 0058
Montreal, Quebec, H3T1E2, Canada
Local Institution - 0057
Montreal, Quebec, H4A3J1, Canada
Local Institution - 0040
Regina, Saskatchewan, S4T1A5, Canada
Local Institution - 0517
Beijing, Beijing Municipality, 100142, China
Local Institution - 0458
Beijing, Beijing Municipality, 101149, China
Local Institution - 0470
Chongqing, Chongqing Municipality, 400030, China
Local Institution - 0493
Fuzhou, Fujian, 350001, China
Local Institution - 0457
Fuzhou, Fujian, 350014, China
Local Institution - 0326
Dongguan Shi, Guangdong, 523059, China
Local Institution - 0331
Guangzhou, Guangdong, 510080, China
Local Institution - 0478
Zhongshan, Guangdong, 528403, China
Local Institution - 0321
Guilin, Guangxi, 541199, China
Local Institution - 0328
Nanning, Guangxi, 530021, China
Local Institution - 0330
Haikou, Hainan, 570000, China
Local Institution - 0343
Harbin, Heilongjiang, 150081, China
Local Institution - 0298
Anyang, Henan, 455000, China
Local Institution - 0341
Weihui Shi, Henan, 453100, China
Local Institution - 0480
Zhengzhou, Henan, 450000, China
Local Institution - 0423
Zhengzhou, Henan, 450008, China
Local Institution - 0483
Jingzhou, Hubei, 0, China
Local Institution - 0450
Wuhan, Hubei, 430022, China
Local Institution - 0482
Changsha, Hunan, 410007, China
Local Institution - 0467
Changsha, Hunan, 410008, China
Local Institution - 0306
Changsha Shi, Hunan, 410013, China
Local Institution - 0347
Nanjing, Jiangsu, 210029, China
Local Institution - 0332
Shenyang, Liaoning, 110042, China
Local Institution - 0464
Xi'an, Shaanxi, 710038, China
Local Institution - 0479
Binzhou, Shandong, 256603, China
Local Institution - 0455
Jinan, Shandong, 250117, China
Local Institution - 0413
Linyi, Shandong, 276027, China
Local Institution - 0469
Weifang Shi, Shandong, 261000, China
Local Institution - 0319
Shanghai Shi, Shanghai Municipality, 200120, China
Local Institution - 0316
Taiyuan, Shanxi, 30001, China
Local Institution - 0463
Taiyuan, Shanxi, 30013, China
Local Institution - 0456
Chengdu, Sichuan, 610041, China
Local Institution - 0471
Chengdu, Sichuan, 610041, China
Local Institution - 0320
Dazhou Shi, Sichuan, 635000, China
Local Institution - 0472
Yibin, Sichuan, 644000, China
Local Institution - 0452
Tianjin, Tianjin Municipality, 300060, China
Local Institution - 0312
Hangzhou, Zhejiang, 310022, China
Local Institution - 0074
Marseille, Bouches-Du-Rhône, 13915, France
Local Institution - 0063
Dijon, Côte-D'Or, 21079, France
Local Institution - 0075
Nantes, Loire Atlantique, 44093, France
Local Institution - 0064
La Tronche, Nan, 38700, France
Local Institution - 0116
Lyon, Nan, 69373, France
Local Institution - 0109
Paris, Nan, 75014, France
Local Institution - 0062
Bron, Rhône, 69677, France
Local Institution - 0069
Villejuif, Val-De-Marne, 94805, France
Local Institution - 0073
Brest, 29200, France
Local Institution - 0066
Caen, 14076, France
Local Institution - 0070
Toulouse, 31059, France
Local Institution - 0071
Paris, Île-de-France Region, 75248, France
Local Institution - 0112
Gerlingen, Baden-Wurttemberg, 70839, Germany
Local Institution - 0111
Ulm, Baden-Wurttemberg, 89081, Germany
Local Institution - 0110
Wangen, Baden-Wurttemberg, 88239, Germany
Local Institution - 0001
Munich, Bavaria, 81377, Germany
Local Institution - 0105
Regensburg, Bavaria, 93053, Germany
Local Institution - 0446
Frankfurt am Main, Hesse, 60389, Germany
Local Institution - 0106
Oldenburg, Lower Saxony, 26121, Germany
Local Institution - 0100
Cologne, North Rhine-Westphalia, 50937, Germany
Local Institution - 0243
Dortmund, North Rhine-Westphalia, 44263, Germany
Local Institution - 0104
Essen, North Rhine-Westphalia, 45147, Germany
Local Institution - 0117
Hemer, North Rhine-Westphalia, 58675, Germany
Local Institution - 0101
Münster, North Rhine-Westphalia, 48149, Germany
Local Institution - 0103
Dresden, Saxony, 1307, Germany
Local Institution - 0412
Leipzig, Saxony, 4103, Germany
Local Institution - 0108
Großhansdorf, Schleswig-Holstein, 22927, Germany
Local Institution - 0239
Lübeck, Schleswig-Holstein, 23538, Germany
Local Institution - 0445
Giessen, 35392, Germany
Local Institution - 0225
Vadodara, Gujarat, 361790, India
Local Institution - 0444
Badsa, Haryana, 124105, India
Local Institution - 0337
Gurgaon, Haryana, 122001, India
Local Institution - 0436
Belagavi, Karnataka, 590010, India
Local Institution - 0215
Pune, Maharashtra, 411013, India
Local Institution - 0233
Mohali, Punjab, 140901, India
Local Institution - 0222
Chennai, Tamil Nadu, 600035, India
Local Institution - 0236
Meldola, Forli-Cesena, 47014, Italy
Local Institution - 0094
Candiolo, Turin, 10060, Italy
Local Institution - 0093
Bergamo, 24128, Italy
Local Institution - 0289
Brescia, 25123, Italy
Local Institution - 0089
Milan, 20133, Italy
Local Institution - 0087
Milan, 20141, Italy
Local Institution - 0238
Milan, 20142, Italy
Local Institution - 0091
Pavia, 27100, Italy
Local Institution - 0088
Verona, 37126, Italy
Local Institution - 0262
Nagoya, Aichi-ken, 464-8681, Japan
Local Institution - 0128
Toon-Shi, Ehime, 791-0295, Japan
Local Institution - 0136
Kurume-Shi, Fukuoka, 830-0011, Japan
Local Institution - 0121
Yokohama, Kanagawa, 241-8515, Japan
Local Institution - 0122
Sendai, Miyagi, 980-0873, Japan
Local Institution - 0433
Okayama, Okayama-ken, 700-8558, Japan
Local Institution - 0125
Hirakata-Shi, Osaka, 573-1191, Japan
Local Institution - 0129
Osakasayama-Shi, Osaka, 589-8511, Japan
Local Institution - 0141
Hamamatsu, Shizuoka, 431-3192, Japan
Local Institution - 0137
Chūōku, Tokyo-To, 104-0045, Japan
Local Institution - 0414
Kōtoku, Tokyo-To, 135-8550, Japan
Local Institution - 0140
Cheongju-si, Chungcheongbuk-do [Chungbuk], 28644, South Korea
Local Institution - 0138
Buk-Gu, Daegu, 41404, South Korea
Local Institution - 0506
Dalseo, Daegu, 42601, South Korea
Local Institution - 0127
Goyang-si, Gyeonggi-do, 410-769, South Korea
Local Institution - 0133
Seongnam-si, Gyeonggi-do, 13620, South Korea
Local Institution - 0134
Hwasun-Gun, Jeollanam-do, 58128, South Korea
Local Institution - 0124
Seocho -Gu, Seoul, 6591, South Korea
Local Institution - 0123
Songpa-Gu, Seoul, 138-736, South Korea
Local Institution - 0139
Gyeongsangnam-do, 050612, South Korea
Local Institution - 0135
Seoul, 120-752, South Korea
Local Institution - 0131
Seoul, 3080, South Korea
Local Institution - 0126
Seoul, 8308, South Korea
Local Institution - 0143
Majadahonda, Madrid, 28222, Spain
Local Institution - 0147
Seville, Seville, 41013, Spain
Local Institution - 0242
A Coruña, 15006, Spain
Local Institution - 0144
Jaén, 23007, Spain
Local Institution - 0226
Jaén, 23007, Spain
Local Institution - 0149
Jerez de la Frontera, 11407, Spain
Local Institution - 0148
Madrid, 28041, Spain
Local Institution - 0150
Málaga, 29010, Spain
Local Institution - 0241
Valencia, 46009, Spain
Local Institution - 0229
Kaohsiung City, Kaohsiung, 82445, Taiwan
Local Institution - 0230
New Taipei City, New Taipei, 23561, Taiwan
Local Institution - 0216
Taipei, Taichung, 112, Taiwan
Local Institution - 0227
Gaoxiongka, Taiwan, 807, Taiwan
Local Institution - 0221
Taoyuan City, Taoyuan, 33378, Taiwan
Local Institution - 0418
Taichung, 40201, Taiwan
Local Institution - 0420
Tainan, 70428, Taiwan
Local Institution - 0419
Taipei, 100225, Taiwan
Local Institution - 0021
Sur, Diyarbakır, 21200, Turkey (Türkiye)
Local Institution - 0265
Pendik, Istanbul, 34340, Turkey (Türkiye)
Local Institution - 0014
Adana, 1060, Turkey (Türkiye)
Local Institution - 0019
Adana, 1370, Turkey (Türkiye)
Local Institution - 0008
Ankara, 6680, Turkey (Türkiye)
Local Institution - 0003
Ankara, 6800, Turkey (Türkiye)
Local Institution - 0015
Antalya, 07100, Turkey (Türkiye)
Local Institution - 0041
Istanbul, 34214, Turkey (Türkiye)
Local Institution - 0039
Istanbul, 34295, Turkey (Türkiye)
Local Institution - 0050
Izmir, 35110, Turkey (Türkiye)
Local Institution - 0037
Izmir, 35530, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bristol-Myers Squibb
Bristol-Myers Squibb
Central Study Contacts
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
First line of the email MUST contain NCT # and Site #.
CONTACT
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2026
First Posted
July 2, 2026
Study Start (Estimated)
September 30, 2026
Primary Completion (Estimated)
December 30, 2031
Study Completion (Estimated)
December 30, 2031
Last Updated
July 15, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- See Plan Description
- Access Criteria
- See Plan Description
BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html